Novartis | NVS - Le Revenu D'Intérêts

Prix De L'Action
145.47
Variation Quotidienne
-2.06 -1.40%
Mensuellement
-3.46%
Annuel
29.62%
Q2 Prévisions
142.62




Le Revenu D'Intérêts Changement Date
AbbVie USD 72M 10M 2025-09
AstraZeneca USD 85M 17M 2025-09
Bausch Health Companies USD 15M 2M 2025-09
Biogen USD 31.6M 700K 2025-09
Corcept Therapeutics USD 5.02M 7K 2025-09
Drreddys Laboratories INR 796M 332M 2025-12
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 26M 24M 2025-09
Glaxosmithkline GBP 26M 24M 2025-09
J&J USD 2.14 237M 2026-03
Merck USD 96M 27M 2025-09
Pacira USD 8.53M 3.53M 2025-09
Pfizer USD 0.62 156M 2025-09
Phibro Animal Health USD 0.08 0.09 2024-12
Sanofi EUR 33M 81M 2025-12
Sanofi EUR 114M 38M 2025-09
Supernus Pharmaceuticals USD 2.28M 2.25M 2025-09
Zoetis USD 26M 7M 2025-09